Effectiveness of remotely delivered speech therapy in persons with Parkinson's disease - a randomised controlled trial.

ABSTRACT:

Background

Increasing evidence supports the merits of speech therapy in Parkinson's disease, but the current practice of multiple in-house treatments is demanding for patients. We therefore assessed the effectiveness of remotely delivered and personalised speech therapy on improving quality of life and speech quality in persons with Parkinson's disease.

Methods

We performed a single blinded randomised controlled trial (the PERSPECTIVE study), comparing 8 weeks of personalised remote speech therapy to no intervention (waiting list design). Patients with reduced speech intelligibility were included, regardless of disease stage or dysarthria severity. Patients were assigned randomly (1:1) to the intervention or control group. Measurements took place at baseline and after 8 week

SUBMITTER: Maas JJL 

PROVIDER: S-EPMC11415969 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature